↓ Skip to main content

The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’

Overview of attention for article published in Supportive Care in Cancer, July 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
24 X users

Citations

dimensions_citation
121 Dimensions

Readers on

mendeley
186 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The development and evaluation of an oncological palliative care deprescribing guideline: the ‘OncPal deprescribing guideline’
Published in
Supportive Care in Cancer, July 2014
DOI 10.1007/s00520-014-2322-0
Pubmed ID
Authors

Julian Lindsay, Michael Dooley, Jennifer Martin, Michael Fay, Alison Kearney, Mohsina Khatun, Michael Barras

Abstract

Current data suggests that potentially inappropriate medicines (PIMs) are common in palliative cancer patients; however, there is a lack of criteria to assist clinicians in identifying PIMs in these patients. The aims of this study were to design and validate a deprescribing guideline for palliative cancer patients and to undertake a descriptive analysis of the identified PIMs.

X Demographics

X Demographics

The data shown below were collected from the profiles of 24 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 186 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
United States 1 <1%
Unknown 184 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 35 19%
Researcher 22 12%
Student > Ph. D. Student 17 9%
Other 16 9%
Student > Doctoral Student 16 9%
Other 46 25%
Unknown 34 18%
Readers by discipline Count As %
Medicine and Dentistry 65 35%
Pharmacology, Toxicology and Pharmaceutical Science 48 26%
Nursing and Health Professions 14 8%
Agricultural and Biological Sciences 2 1%
Economics, Econometrics and Finance 2 1%
Other 5 3%
Unknown 50 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2020.
All research outputs
#1,539,759
of 25,401,784 outputs
Outputs from Supportive Care in Cancer
#168
of 5,063 outputs
Outputs of similar age
#15,043
of 242,250 outputs
Outputs of similar age from Supportive Care in Cancer
#3
of 64 outputs
Altmetric has tracked 25,401,784 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,063 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 242,250 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.